Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.

Stein MD, Kenney SR, Anderson BJ, Conti MT, Bailey GL.

J Subst Abuse Treat. 2020 Mar;110:37-41. doi: 10.1016/j.jsat.2019.12.007. Epub 2019 Dec 13.

PMID:
31952626
2.

Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016.

Zhou L, Bhattacharjee S, Kwoh CK, Tighe PJ, Malone DC, Slack M, Wilson DL, Brown JD, Lo-Ciganic WH.

J Clin Med. 2019 Dec 29;9(1). pii: E83. doi: 10.3390/jcm9010083.

3.

Trends in gabapentin and baclofen exposures reported to U.S. poison centers.

Reynolds K, Kaufman R, Korenoski A, Fennimore L, Shulman J, Lynch M.

Clin Toxicol (Phila). 2019 Dec 1:1-10. doi: 10.1080/15563650.2019.1687902. [Epub ahead of print]

PMID:
31786961
4.

Intranasal Pregabalin Administration: A Review of the Literature and the Worldwide Spontaneous Reporting System of Adverse Drug Reactions.

Elsayed M, Zeiss R, Gahr M, Connemann BJ, Schönfeldt-Lecuona C.

Brain Sci. 2019 Nov 13;9(11). pii: E322. doi: 10.3390/brainsci9110322.

5.

Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.

Vickers-Smith R, Sun J, Charnigo RJ, Lofwall MR, Walsh SL, Havens JR.

Drug Alcohol Depend. 2020 Jan 1;206:107709. doi: 10.1016/j.drugalcdep.2019.107709. Epub 2019 Nov 2.

PMID:
31732295
6.

Management of pregabalin and gabapentin prescribing and use in NSW prisons.

Nicholls G, Samios P, Hampton S.

Med J Aust. 2019 Nov;211(10):474-474.e1. doi: 10.5694/mja2.50398. Epub 2019 Oct 31. No abstract available.

PMID:
31674028
7.

"That's what we call the cocktail": Non-Opioid medication and supplement misuse among opioid users.

Chatterjee A, Lopez D, Ramkellawan S, Brown R, Smith K, Gaeta JM, Baggett TP.

Subst Abus. 2019 Oct 22:1-8. doi: 10.1080/08897077.2019.1671943. [Epub ahead of print]

PMID:
31638874
8.

Prescribing trends of gabapentin, pregabalin, and oxycodone: a secondary analysis of primary care prescribing patterns in England.

Green K, Cooke O'Dowd N, Watt H, Majeed A, Pinder RJ.

BJGP Open. 2019 Oct 29;3(3). pii: bjgpopen19X101662. doi: 10.3399/bjgpopen19X101662. Print 2019 Oct.

9.

An ethnographic decision model of the initiation of gabapentin misuse among prescription and/or illicit opioid (mis)user.

Buttram ME, Kurtz SP, Cicero TJ, Havens JR.

Drug Alcohol Depend. 2019 Nov 1;204:107554. doi: 10.1016/j.drugalcdep.2019.107554. Epub 2019 Sep 13.

PMID:
31542629
10.

Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers.

Buttram ME, Kurtz SP, Ellis MS, Cicero TJ.

J Subst Abuse Treat. 2019 Oct;105:1-4. doi: 10.1016/j.jsat.2019.07.011. Epub 2019 Jul 21.

PMID:
31443885
11.

Validation of a High-throughput Screening and Quantification Method for the Determination of Gabapentinoids in Blood Using a Combination of LC-TOF-MS and LC-MS-MS.

De La Vega H, Fox K, Pardi J, Santiago-Tirado W, Cooper G.

J Anal Toxicol. 2019 Oct 17;43(9):696-702. doi: 10.1093/jat/bkz070.

PMID:
31436295
12.

Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).

Evoy KE, Covvey JR, Peckham AM, Ochs L, Hultgren KE.

Res Social Adm Pharm. 2019 Aug;15(8):953-958. doi: 10.1016/j.sapharm.2018.06.018. Epub 2018 Jun 28.

PMID:
31303196
13.

Effect of Surgery-Specific Opioid-Prescribing Education in a Safety-Net Hospital.

Yorkgitis BK, Paffett C, Brat GA, Crandall M.

J Surg Res. 2019 Nov;243:71-74. doi: 10.1016/j.jss.2019.05.003. Epub 2019 May 31.

PMID:
31158726
14.

Misuse and Mortality Related to Gabapentin and Pregabalin are Being Under-Estimated: A Two-Year Post-Mortem Population Study.

Nahar LK, Murphy KG, Paterson S.

J Anal Toxicol. 2019 Aug 23;43(7):564-570. doi: 10.1093/jat/bkz036.

PMID:
31062862
15.

Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery.

Landau R.

Int J Obstet Anesth. 2019 Aug;39:105-116. doi: 10.1016/j.ijoa.2019.01.011. Epub 2019 Feb 10. Review.

PMID:
31005380
16.

Quantifying Gabapentin Misuse With Opioids.

Peckham AM, Sclar DA.

Prim Care Companion CNS Disord. 2019 Mar 14;21(2). pii: 18l02386. doi: 10.4088/PCC.18l02386. No abstract available.

17.

Regulating gabapentin as a drug of abuse: A survey study of Kentucky community pharmacists.

Blackmer J, Lindahl E, Strahl A, Schadler A, Freeman PR.

J Am Pharm Assoc (2003). 2019 May - Jun;59(3):379-382. doi: 10.1016/j.japh.2018.12.018. Epub 2019 Feb 18.

PMID:
30786971
18.

Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Driot D, Jouanjus E, Oustric S, Dupouy J, Lapeyre-Mestre M.

Br J Clin Pharmacol. 2019 Jun;85(6):1260-1269. doi: 10.1111/bcp.13892. Epub 2019 Mar 28.

PMID:
30737829
19.

Gabapentin-related Deaths: Patterns of Abuse and Postmortem Levels.

Tharp AM, Hobron K, Wright T.

J Forensic Sci. 2019 Jul;64(4):1105-1111. doi: 10.1111/1556-4029.14021. Epub 2019 Feb 7.

PMID:
30731020
20.

Gabapentin misuse.

Lennox R, Mangin D.

CMAJ. 2019 Jan 14;191(2):E47. doi: 10.1503/cmaj.180599. No abstract available.

Supplemental Content

Loading ...
Support Center